Skip to content

Effects of Transcutaneous Electrical Nerve Stimulation over Acupoint for risk of COPD Exacerbation

Effects of Transcutaneous Electrical Nerve Stimulation over Acupoint for risk of COPD Exacerbation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045989
Enrollment
Unknown
Registered
2021-05-01
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Sponsors

Chengdu Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Comply with the diagnosis of "lung distension" in Chinese medicine; 2. Comply with the diagnosis of "chronic obstructive pulmonary disease" in western medicine, and it is in a stable phase; 3. Aged 40 to 75 years; 4. Clear consciousness, answer the questions to the point, and be able to walk independently or with support; 5. Be informed and sign the consent form; 6. Have not experienced transcutaneous electrical acupoint stimulation in the past.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, brain, blood vessels, liver and kidney dysfunction, cancer patients,and severe mental disorders; 2. Pregnant and lactating women; 3. Have an acute exacerbation of COPD in three months; 4. Have attended any other studies in six months; 5. Allergic to the sticking agent.

Design outcomes

Primary

MeasureTime frame
frequency of exacerbations;hospital admissions;

Secondary

MeasureTime frame
lung function;6 minutes walking distance;

Countries

China

Contacts

Public ContactWang Yan

Chengdu Fifth People's Hospital Affiliated to Chengdu University of Traditional Chinese Medicine

wy751105@126.com+86 28 82741426

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026